Navigation Links
Julia Quinlan to present awards at a conference hosted by Rutgers College of Nursing
Date:3/18/2008

(NEWARK, N.J., March 18, 2008) Julia Duane Quinlan, mother of Karen Ann Quinlan, whose legal battle to remove her daughter from a respirator changed the use of life-support for the dying, will present the second annual Joe and Julia Quinlan Award to Dr. John Gregory from Overlook Hospital, Summit, N.J., and posthumously to Rev. Charles J. Hudson and Margaret J. Coloney from the Center for Hope Hospice, Scotch Plains, N.J., during the third annual New Jersey-End-of-Life Nursing Education Consortium on March 27.

The conference, hosted by the College of Nursing Center for Professional Development at Rutgers, The State University of New Jersey, will be held at the Sheraton Atlantic City Convention Center Hotel in Atlantic City, N.J., March 27-28.

The Joe and Julia Quinlan Award is given to a New Jersey layperson, professional or volunteer who has made a significant difference in the provision of palliative care, hospice care or end of life care.

This interdisciplinary conference is intended for health care professionals to learn about best practices in end-of-life and palliative care. NJ-ELNEC will feature such speakers as Dr. R. Sean Morrison, director of the National Palliative Care Research Center; Rev. Kathleen Rusnak, former director of Spiritual Care at The Connecticut Hospice; William P. Isele, former New Jersey ombudsman for the Institutionalized Elderly; Regina S. Cunningham, chief nursing officer at Cancer Institute of New Jersey and assistant professor in the Research Division, Department of Family Medicine at UMDNJ-Robert Wood Johnson Medical School; Dr. Richard Payne, a leading expert in pain relief, care for those near death, oncology and neurology; and Jay Tashiro, chief executive officer and founder of Wolfsong Informatics.

To register or for more information, call the College of Nursing Center for Professional Development at (973) 353-5895 or register online at http://nu
'/>"/>

Contact: Miguel Tersy
mtersy@rutgers.edu
973-353-5293
Rutgers University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
2. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
3. Hologic to Present at Lehman Brothers Healthcare Conference
4. Bristol-Myers Squibb to Present at Healthcare Conferences
5. Exponent to Present at Sidoti and B. Riley Conferences
6. NBTY to Web Cast Presentation at Citigroup Small and Mid-Cap Conference
7. West Pharmaceutical Services to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
8. Exelixis Announces March 19 Webcast of Presentation at the Lehman Brothers Annual Global Healthcare Conference
9. Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference
10. MannKind to Present at the Cowen and Company Healthcare Conference
11. Brookdale to Present at Lehman Global Healthcare Conference on March 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...LUMBIA, S.C., Nov. 21 U...ttee for Quality Assurance (NCQA) ranked BlueChoic... of America,s Best Health Plans(TM), published in ... , The respected annual ranking ranks the na..., member satisfaction and NCQA accreditation score...
(Date:11/21/2008)...periments in mice find running increases productio...21 (HealthDay News) -- In experiments in mice, exe...tion of brain stem cells usually seen with aging, ... restoration of the brain,s ability to stave off a...store a neurochemical that is essential for the pr...
(Date:11/21/2008)...RSAW, Ind., Nov. 21 Symm...ndent provider of products to the global orthopedi...nced today that Brian S. Moore, President and Chie... President and Chief Financial Officer, are schedu...alth Care Conference at The New York Palace Hotel ...
(Date:11/21/2008)...NNEAPOLIS, Nov. 21 Three Minnesota... prizes during a special on-ice presentation at,t...Energy Center. The winners,were participants in T...from,ClearWay Minnesota(SM) and QUITPLAN(R) Servi...$5,000 in cash, while two runners-up,will get $1,...
Breaking Medicine News(10 mins):Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Exercise Keeps the Brain Young 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2
... reported a study which states that fat men are ab.../This research was conducted by a team of research...this study, when obese men were hospitalized with ...ate better than thin men. This is said to be due t...
...al giant Novartis bagged the contract to make a ch...flu vaccines. The $54.8 million contract// was fin... than $300 million in federal contracts to fight a... in humans. Two other firms were also awarded con...
...searchers have developed a powerful method for cha...es called nucleosomes throughout the human genome/...clues for understanding and diagnosing cancer and ...may shed light on the role of nucleosomes in the p...
...y Commission said on Wednesday that about 375,000 ... Teether Beads are being recalled// because they p...at holds the teether beads in place can crack or b...e distributor, Kids II Inc. of Alpharetta, Ga., ha...
Other Medicine News:Health News:Scientists Map Key Landmarks in Human Genome 2Health News:Scientists Map Key Landmarks in Human Genome 3
(Date:11/20/2008)... PRELIMINARY TOP LINE RESULTS OF FIRST PHASE III ... FATIGUE, AND IMPROVEMENT IN DAILY FUNCTION, IN, ... , PALO ALTO, Calif., and BRUSSELS, Belgium, No...als, Inc. (Nasdaq: JAZZ ) and UCB (Euronext Brus...op-line results from the first of two,Phase III p...
(Date:11/20/2008)...VERSIDE, Calif., Nov. 20 Milk. It ...er than originally thought. After years of,resear...d peptides found in,cow,s milk that stimulate the... To view the Multimedia News Release, go to:, ht..., , While developing new cancer therapies, ...
(Date:11/20/2008)... JOLLA, Calif., Nov. 20 ...KA), announced today that it has submitted its,pi...eview under a Special,Protocol Assessment (SPA) p...n,(FDA). , Subject to securing an agreemen...e, prospective, double-blind, placebo-controlled a...
(Date:11/20/2008)...W YORK, Nov. 20 Clinical data from...e 35th Annual Veith Symposium shows DVT,treatment...om Bacchus,Vascular, Inc. (Santa Clara, CA) succe... in about 20 minutes. , This technique, cal...ores,blood flow more quickly and safely than curr...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 1Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 2Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 3Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 4Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 5Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 6Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 7Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 8Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 9Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 10Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 11Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 12Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 13Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 14Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 15Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 16Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 17Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 18Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 19Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 20Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 21Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 22Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 23Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 24Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 1Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 2Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 3Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 4Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 5Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 6Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 7Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 8Brokers Name Delta Dental the Best in Coverage Plan Design and Networks 6284 1Brokers Name Delta Dental the Best in Coverage Plan Design and Networks 6284 2New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 1New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 2New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 3
...USINESS WIRE)--Jun 7, 2007 - Clinical results from...the American,Headache Society (AHS) annual meeting...itonin gene-related peptide (CGRP),receptor antago...two hours after dosing compared to placebo, and th...as generally well tolerated in,the study. Response...
...hieves All Key Endpoints for Both Efficacy and Saf...irstCall/ --,Indevus Pharmaceuticals, Inc. today a...kinetic trial for NEBIDO (testosterone,undecanoate...under,development for the treatment of male hypogo...ing Pharma AG, Germany. The data,from the recently...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6
Portable - Battery Powered (6 size AA required). Fast, Lightweight Strain Gage Mechanism. Unit conversion (g, ct, oz, ozt, GN, dwt, mom, dwt, tael), Specific Gravity calculation, Piece Counting and P
...speed, stability and durability. Back-lighted Disp...es, multiple units of measure, piece counting and .../ISO output including date and time data from buil...ights only (selectable range). Shimadzu WindowsDir...
...tal stability control, analog display modes, multi...easure functions, auto print, and GLP/GMP/ISO outp...k. Touch-key calibration with external weights (s...face, WindowsDirect Capable. 120/240V A/C adapter,...
The EK-H Series offer 10 selectable units of measure
Medicine Products: